Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation

International Journal of Hematology

Volumn 75, Issue 2, 2002, Pages 201-206

  Tezuka, Kayo ^a   Nakayama, Hideki ^a,d   Honda, Keiko ^a   Suzumiya, Junji ^a   Oshima, Kouichi ^a   Kitoh, Toshiyuki ^b   Ishii, Eiichi ^a,c  

^a FUKUOKA UNIVERSITY   (Japan)

^b Shiga Medical Center for Children   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d HAMANOMACHI HOSPITAL   (Japan)

Author keywords

Childhood leukemia; Chromosomal abnormality; Cord blood transplantation; L asparaginase; Myeloid NK cell precursor

Indexed keywords

ASPARAGINASE; CD2 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; ANTINEOPLASTIC AGENT;

ACUTE LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLAST CELL; BONE MARROW CELL; CASE REPORT; CHILDHOOD LEUKEMIA; CHROMOSOME ANALYSIS; CONDITIONING; CORD BLOOD TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPHADENOPATHY; MALE; MULTIMODALITY CANCER THERAPY; MYELOID NATURAL KILLER CELL PRECURSOR ACUTE LEUKEMIA; NATURAL KILLER CELL; PRESCHOOL CHILD; SOUTHERN BLOTTING; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION; ACUTE DISEASE; DRUG EFFECT; FETUS BLOOD; MYELOID LEUKEMIA; PATHOLOGY; REMISSION; STEM CELL TRANSPLANTATION;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FETAL BLOOD; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID; MALE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION;

EID: 0036463828     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982029     Document Type: Article

References (17)

1. Suzuki R, Yamamoto K, Seto M, et al. CD7 and CD56 myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90:2417-2428.
2. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor or acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res. 1999;23:615-624.
3. Scott AA, Head DR, Kopeckey KJ, et al. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994;84:244-255.
4. Nagata T, Higashigawa M, Nagai M, et al. A child case of C34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement. Leuk Res. 1996;20:983-985.
5. DiGiusppe JA, Louie DC, Williams JE, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol. 1997;21:1223-1230.
6. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol. 1995;19:284-296.
7. Sanchez, MJ, Muench MO, Roncarolo MG, et al. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med. 1994;180:569-576.
8. Shibuya A, Nagayoshi K, Nakamura K, et al. Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1995;85:3538-3546.
9. Kuetzberg J, Waldmann TA, Davey MP, et al. CD7+, CD4-, CD8-, acute leukemia: a syndrome of malignant pulripotent lymphohematopoietic cells. Blood. 1989;73:381-390.
10. Inaba T, Shimazaki C, Sumikuma T, et al. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia. Leuk Res. 2001;25:109-113.
11. Obama K, Tara M, Niina K. L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma. Int J Hematol. 1999;69:260-262.
12. Kitoh E, Nishimura S, Shirahase H, et al. Immunocytochemical analysis of asparagine synthetase protein of leukemia cells: indication for L-asparaginase treatment [abstract]. Blood. 1996;88(suppl 1):86a.
13. Kitoh T, Sawada M, Shirahase H, et al. Asparagine synthetase protein expression in leukemia cells: application of L-asparaginase treatment for leukemia [abstract]. Blood. 1998;92(suppl 1):400a.
14. Rocha V, Cornish J, Sievers E, et al. Comparison of the outcome of unrelated bone marrow (BM) or cord blood (CB) transplantation in children with acute leukemia (AL) [abstract]. Blood. 1999;94(suppl 1):712a.
15. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood. 1999;93:3662-3671.
16. Mogul MJ. Unrelated cord blood transplantation vs. matched unrelated donor bone marrow transplantation: the risks and benefits of each choice. Bone Marrow Transplant. 2000;25(suppl 2):S58-S60.
17. Yoshino H, Tanaka R, Yoshimaru T, et al. Allogeneic bone marrow transplantation from the HLA one-locus mismatched father for a child of myeloid/NK cell precursor acute leukemia with late relapse [in Japanese; abstract]. The 42nd Annual Meeting of Japanese Society of Pediatric Hematology. 2000;14:85.